Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001144204-11-040622
Filing Date
2011-07-14
Accepted
2011-07-14 17:21:49
Documents
30
Period of Report
2011-03-31

Document Format Files

Seq Description Document Type Size
1 v228607_10k.htm 10-K 1368729
2 GRAPHIC chart.jpg GRAPHIC 19038
3 v228607_ex10-3.htm EX-10.3 17022
4 v228607_ex10-4.htm EX-10.4 12719
5 v228607_ex10-5.htm EX-10.5 6325
6 v228607_ex10-6.htm EX-10.6 3608
7 GRAPHIC ex10-6pg01.jpg GRAPHIC 614117
8 GRAPHIC ex10-6pg02.jpg GRAPHIC 632690
9 GRAPHIC ex10-6pg03.jpg GRAPHIC 629924
10 GRAPHIC ex10-6pg04.jpg GRAPHIC 384961
11 v228607_ex10-7.htm EX-10.7 1991
12 GRAPHIC ex10-7pg01.jpg GRAPHIC 279851
13 GRAPHIC ex10-7pg02.jpg GRAPHIC 450689
14 v228607_ex10-8.htm EX-10.8 11425
15 v228607_ex10-9.htm EX-10.9 11425
16 v228607_ex10-10.htm EX-10.10 16180
17 v228607_ex10-11.htm EX-10.11 12103
18 v228607_ex10-12.htm EX-10.12 14026
19 v228607_ex10-13.htm EX-10.13 9476
20 v228607_ex10-14.htm EX-10.14 980
21 GRAPHIC v228607_ex10-14x1x1.jpg GRAPHIC 86701
22 GRAPHIC v228607_ex10-14x2x1.jpg GRAPHIC 105036
23 GRAPHIC v228607_ex10-14x3x1.jpg GRAPHIC 87276
24 GRAPHIC v228607_ex10-14x4x1.jpg GRAPHIC 41155
25 v228607_ex10-15.htm EX-10.15 6255
26 v228607_ex21-1.htm EX-21.1 2817
27 v228607_ex31-1.htm EX-31.1 14964
28 v228607_ex31-2.htm EX-31.2 14832
29 v228607_ex32-1.htm EX-32.1 6387
30 v228607_ex32-2.htm EX-32.2 6406
  Complete submission text file 0001144204-11-040622.txt   6130501
Mailing Address 125 MAIDEN LANE, SUITE 309 NEW YORK NY 10038
Business Address 125 MAIDEN LANE, SUITE 309 NEW YORK NY 10038 212-797-9877
Tongli Pharmaceuticals (USA), Inc. (Filer) CIK: 0001052284 (see all company filings)

EIN.: 841090791 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-52954 | Film No.: 11968593
SIC: 2834 Pharmaceutical Preparations